• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型血管性血友病诊断中的争议

Controversies in the diagnosis of Type 1 von Willebrand disease.

作者信息

Bowman M L, James P D

机构信息

Department of Medicine, Queen's University, Kingston, ON, Canada.

Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.

出版信息

Int J Lab Hematol. 2017 May;39 Suppl 1:61-68. doi: 10.1111/ijlh.12653.

DOI:10.1111/ijlh.12653
PMID:28447419
Abstract

von Willebrand disease (VWD) is the most common bleeding disorder. Type 1 VWD represents the majority of cases and results from a partial quantitative deficiency of von Willebrand factor (VWF). The diagnosis of Type 1 VWD presents many challenges, despite there being three established diagnostic criteria: a personal history of mucocutaneous bleeding, a family history and low VWF levels. These criteria do not always coexist, and there is great overlap of clinical phenotypes and laboratory parameters between healthy individuals and those with VWD. Mild bleeding symptoms can have any number of causes and bleeding is commonly reported in the general population. VWF levels do not always correlate with bleeding symptoms and can be variable between affected family members. Additionally, VWF levels vary widely as a result of both genetic and non-genetic influences. Perhaps the greatest current controversy in the diagnosis of Type 1 VWD is that there is no consensus laboratory cut-off for the diagnosis, raising concern about both over- and under-diagnosis. Ongoing studies are addressing these issues by clarifying the underlying pathogenesis of the disease, as well as the natural history and the risk of future bleeding in those with the diagnosis.

摘要

血管性血友病(VWD)是最常见的出血性疾病。1型VWD占大多数病例,是由血管性血友病因子(VWF)部分定量缺乏所致。尽管有三项既定的诊断标准:黏膜皮肤出血的个人史、家族史和低VWF水平,但1型VWD的诊断仍面临许多挑战。这些标准并不总是同时存在,健康个体与VWD患者之间的临床表型和实验室参数存在很大重叠。轻度出血症状可能有多种原因,而且一般人群中普遍报告有出血情况。VWF水平并不总是与出血症状相关,且在受影响的家庭成员之间可能存在差异。此外,由于遗传和非遗传影响,VWF水平差异很大。目前1型VWD诊断中最大的争议可能在于,对于诊断没有达成共识的实验室临界值,这引发了对过度诊断和诊断不足的担忧。正在进行的研究通过阐明该疾病的潜在发病机制以及确诊者的自然病史和未来出血风险来解决这些问题。

相似文献

1
Controversies in the diagnosis of Type 1 von Willebrand disease.1型血管性血友病诊断中的争议
Int J Lab Hematol. 2017 May;39 Suppl 1:61-68. doi: 10.1111/ijlh.12653.
2
CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.CLEC4M 和 STXBP5 基因突变可导致血管性血友病患者 von Willebrand 因子水平的变化。
J Thromb Haemost. 2015 Jun;13(6):956-66. doi: 10.1111/jth.12927. Epub 2015 May 9.
3
Quantitative impact of using different criteria for the laboratory diagnosis of type 1 von Willebrand disease.不同实验室诊断 1 型血管性血友病标准的定量影响。
J Thromb Haemost. 2014 Aug;12(8):1238-43. doi: 10.1111/jth.12594. Epub 2014 Jun 27.
4
Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.美国一组诊断为1型血管性血友病(VWD)患者的临床和实验室变异性。
Blood. 2016 May 19;127(20):2481-8. doi: 10.1182/blood-2015-10-673681. Epub 2016 Feb 9.
5
How I treat low von Willebrand factor levels.如何治疗低血管性血友病因子水平。
Blood. 2019 Feb 21;133(8):795-804. doi: 10.1182/blood-2018-10-844936. Epub 2018 Dec 21.
6
Low von Willebrand factor: sometimes a risk factor and sometimes a disease.低血管性血友病因子:有时是风险因素,有时是疾病。
Hematology Am Soc Hematol Educ Program. 2009:106-12. doi: 10.1182/asheducation-2009.1.106.
7
Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in type 1 von Willebrand disease patients.STXBP5 和 STX2 基因变异对 1 型血管性血友病患者血管性血友病因子和出血表型的影响。
PLoS One. 2012;7(7):e40624. doi: 10.1371/journal.pone.0040624. Epub 2012 Jul 6.
8
Laboratory diagnostic approach of the parents-children relationship in differentiating low-level von Willebrand factor from mild type 1 von Willebrand disease.区分低水平血管性血友病因子与轻型1型血管性血友病疾病时亲子关系的实验室诊断方法
Blood Coagul Fibrinolysis. 2012 Jun;23(4):351-3. doi: 10.1097/MBC.0b013e32835274f1.
9
Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees.两个中国家系中2N型血管性血友病与严重A型血友病合并1型血管性血友病时关节和黏膜出血综合征的相似性
Blood Cells Mol Dis. 2014 Apr;52(4):181-5. doi: 10.1016/j.bcmd.2013.11.005. Epub 2013 Dec 16.
10
Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.1 型血管性血友病患者出血倾向和抗出血治疗效果与血管性血友病因子清除率增加。
Thromb Haemost. 2011 Apr;105(4):647-54. doi: 10.1160/TH10-11-0697. Epub 2011 Jan 25.

引用本文的文献

1
Dental Implants and Orthodontic Mini-Screws in a Patient with Undiagnosed Von Willebrand's Disease: A Case Report.未确诊的血管性血友病患者的牙种植体与正畸微螺钉:一例报告
Dent J (Basel). 2024 Nov 25;12(12):381. doi: 10.3390/dj12120381.
2
A fully humanized von Willebrand disease type 1 mouse model as unique platform to investigate novel therapeutic options.一种完全人源化的1型血管性血友病小鼠模型,作为研究新型治疗方案的独特平台。
Haematologica. 2025 Apr 1;110(4):923-937. doi: 10.3324/haematol.2024.286076. Epub 2024 Nov 28.
3
Application of genetic testing for the diagnosis of von Willebrand disease.
遗传性血管性血友病(von Willebrand 病)的基因检测应用。
J Thromb Haemost. 2024 Aug;22(8):2115-2128. doi: 10.1016/j.jtha.2024.05.006. Epub 2024 May 16.
4
Clinical and laboratory presentation of von Willebrand disease: Experience from a single center in Saudi Arabia.血管性血友病的临床及实验室表现:来自沙特阿拉伯单一中心的经验
J Taibah Univ Med Sci. 2022 Nov 14;18(2):413-419. doi: 10.1016/j.jtumed.2022.10.019. eCollection 2023 Apr.
5
Cryptogenic oozers and bruisers.隐匿性渗出性淤斑和瘀斑性淤斑。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):85-91. doi: 10.1182/hematology.2021000236.
6
Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding.低血管性血友病因子诊断标准及预测未来出血的风险评分
J Thromb Haemost. 2021 Mar;19(3):719-731. doi: 10.1111/jth.15227. Epub 2021 Jan 24.
7
Congenital Bleeding Disorders amid the COVID-19 pandemic: Open questions and recommendations.新冠疫情期间的先天性出血性疾病:未解决的问题与建议
Acta Biomed. 2020 Sep 7;91(3):e2020028. doi: 10.23750/abm.v91i3.10203.
8
New developments in von Willebrand disease.血管性血友病的新进展。
Br J Haematol. 2020 Nov;191(3):329-339. doi: 10.1111/bjh.16681. Epub 2020 May 12.
9
Targeted re-sequencing of F8, F9 and VWF: Characterization of Ion Torrent data and clinical implications for mutation screening.F8、F9 和 VWF 的靶向重测序:离子激流数据的特征分析及其对突变筛查的临床意义。
PLoS One. 2019 Apr 26;14(4):e0216179. doi: 10.1371/journal.pone.0216179. eCollection 2019.
10
Closing the gap - detection of clinically relevant von Willebrand disease in emergency settings through an improved algorithm based on rotational Thromboelastometry.缩小差距 - 通过基于旋转血栓弹性描记术的改良算法在急诊环境中检测临床相关的血管性血友病。
BMC Anesthesiol. 2019 Jan 10;19(1):10. doi: 10.1186/s12871-018-0672-8.